Locations
Paris, France · villejuif, france · Paris, France
industry
Biotechnology · DeepTech · Health
Stage
Seed
founded in
2023
Orakl Oncology is a pioneering precision oncology company that accelerates drug development through an AI-powered techbio platform. Founded in 2023, the company leverages real-world patient data and advanced biology to create individualized patient avatars, which significantly improve clinical trial outcomes and drug development processes. With a focus on colorectal and pancreatic cancers, Orakl's solutions, O-Predict and O-Validate, aim to transform oncology drug development by providing best-in-class predictions and biological evidence of causality. The company has raised €11 million in funding to support its growth and strategic partnerships in the pharmaceutical sector, positioning itself as a leader in precision medicine.
Is this your company?
Something looks off?
On-site & Remote
